Modulation of major histocompatibility class II protein expression by varicella-zoster virus

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Cell surface major histocompatibility complex (MHC) class II molecules are crucial for immune surveillance.
• Gamma interferon (IFN-gamma) is a key cytokine that upregulates MHC class II expression.
• Varicella-zoster virus (VZV) is a human herpesvirus known to cause chickenpox and shingles.

Purpose of the Study:

• To investigate the impact of VZV infection on IFN-gamma-induced MHC class II expression in human fibroblasts.
• To elucidate the molecular mechanisms by which VZV interferes with IFN-gamma signaling.

Main Methods:

• Human fibroblasts were infected with VZV before or after IFN-gamma stimulation.
• Cell surface MHC class II expression was assessed using flow cytometry.
• In situ hybridization and Northern blot analysis were used to examine MHC class II mRNA levels.
• Protein expression of key signaling molecules (Stat1alpha, Jak1, Jak2) and regulatory factors was analyzed.

Main Results:

• VZV infection prior to IFN-gamma treatment significantly reduced MHC class II expression.
• VZV infection inhibited the accumulation of MHC class II mRNA and the expression of Stat1alpha and Jak2 proteins.
• VZV interfered with the IFN-gamma signaling pathway by inhibiting interferon regulatory factor 1 and MHC class II transactivator transcription.
• MHC class II transcripts were detected around VZV lesions in skin biopsies, but not within VZV-infected cells.

Conclusions:

• VZV possesses an immunomodulatory function that directly inhibits IFN-gamma-induced MHC class II expression.
• This inhibition is mediated through interference with the Jak/Stat signaling pathway.
• Suppression of MHC class II expression may allow VZV to evade CD4(+) T-cell immune surveillance, promoting viral replication and transmission.